SEARCH:      Monitor Keywords |  Custom RSS

Organic compounds -- part of the class 532-570 series February patent applications/inventions, industry category 02/11

20110046366 - Liquid porphyrin derivative, and method for producing the same: wherein M represents 2H (hydrogen atoms) or an atom or compound capable of binding covalently or coordinately to tetraphenylporphyrin; each of R1, R2, and R3 independently represents a hydrogen atom, or an alkoxy group having 7 to 14 or 15 carbon atoms represented by OR4; R4 represents a substituted or... Agent: Ladas & Parry LLP

20110046367 - 3-3-di-substituted-oxindoles as inhibitors of translation initiation: Compositions and methods for inhibiting translation using 3-(5-tert-Butyl-2-Hydroxy-phenyl)-3-phenyl-1,3-dihydro-indol-2-one and/or its derivatives are provided. Compositions, methods and kits for treating (1) cellular proliferative disorders, (2) non-proliferative, degenerative disorders, (3) viral infections, and/or (4) disorders associated with viral infections, using 3-(5-tert-butyl-2-hydroxy-phenyl)-3-phenyl-1,3-dihydro-indol-2-one and/or its derivatives are described.... Agent: Banner & Witcoff, Ltd.

20110046368 - Ligands of 5-ht6 receptors, a pharmaceutical composition, method for the production and use thereof: Wherein R2 and R3 independently of each other represent an amino group substituent selected from hydrogen; substituted carbonyl; substituted aminocarbonyl; substituted aminothiocarbonyl; substituted sulphonyl; C1-C5-alkyl optionally substituted by: C6-C10-arylaminocarbonyl, heterocyclyl, C6-C10-arylaminocarbonyl, C6-C10-arylaminothiocarbonyl, C5-C10-azaheteroaryl, optionally substituted carboxyl, nitryl group, optionally substituted aryl; R1k represents from 1 to 3 substituents of cyclic... Agent: Sughrue Mion, PLLC

20110040086 - Novel beta-lactam antibiotics, methods for their production, and their use: The invention relates to novel antimicrobial agents that are based on β-lactam derivatives and are produced by reacting previously known β-lactam derivatives with polyphenol oxidase substrates under the influence of free radicals and by forming salts of any β-lactam derivatives with polyhexamethylene biguanide hydrogen carbonate. Said novel compounds are suitable... Agent: Panitch Schwarze Belisario & Nadel LLP

20110040087 - Peptide turn mimetics: Peptide mimetics of structure X herein which (i) provide a wide range of sidechain functions at all sidechain positions, (ii) can be incorporated in a peptide sequence, (iii) can be readily synthesized and (iv) have a variety of conformations. There is also provided a novel process which can provide valuable... Agent: Schwegman, Lundberg & Woessner, P.A.

20110040088 - Fused heterocyclic compounds: Certain fused pyrrole- and pyrazole-containing heterocyclic compounds are serotonin modulators useful in the treatment of serotonin-mediated diseases.... Agent: Philip S. Johnson Johnson & Johnson

20110034686 - Process for isolation and purification of geldanamycin: The present invention is successful in providing a suitable process for the isolation and purification of geldanamycin. The process provided in the instant invention is easy to scale-up, industrially safe and will give high yield and productivity.... Agent: Dla Piper LLP (us)

20110034687 - Process for producing amide or lactam: The present invention relates to a process for producing an amide or lactam, particularly laurolactam, wherein catalytic amounts of an acidic chloride and a Lewis acid are used in Beckmann rearrangement of an oxime compound. In accordance with the process, side reactions during Beckmann rearrangement can be so controlled that... Agent: Knobbe Martens Olson & Bear LLP

20110034688 - Optically active dibenzazepine derivatives: It is to provide a novel optically active dibenzazepine derivative having a high utility value as an asymmetric phase-transfer catalyst. It is an optically active 6,7-dihydro-5H-dibenzo[c,e]azepine derivative represented by the following formula (1′), (wherein R represents a divalent organic group for cross-linking the 1st position and the 11th position; R1... Agent: Oliff & Berridge, PLC

20110028711 - Unsaturated steroid compounds: The instant invention provides potent antiandrogen compounds, such as 3β-acetoxyandrost-1,5-diene-17-ethylene ketal and 3β-hydroxyandrost-1,5-diene-17-ethylene ketal, and methods for their use in the prevention and treatment of biological conditions mediated by androgen receptors. Thus, for example, compounds of the invention are useful in the prevention and treatment of prostrate cancer. Furthermore, it... Agent: Harbor Biosciences, Inc.

20110028712 - Diamine salts of carboxylic acids: The present invention relates to a salt of a carboxylic acid with a diamine such as 2,2′-(ethylenedioxy)diethyl amine, 3,3′-(ethylenedioxy)dipropyl amine and 2,2′-oxybis(ethylamine) and a method of preparing such salts. Preferably the carboxylic acid is a fermentation product such as clavulanic acid, mycophenolic acid or pravastatin.... Agent: Nixon & Vanderhye, PC

20110028713 - Aza compounds and production method thereof, and metal complexes as mri contrast agents: A core of a cyclic structure represented by (—N—(CH2)n—)k is bonded to a dendrimer-type side chain with a specific branched structure at all nitrogen atoms in the core to produce a compound with a specific structure for producing a metal complex that exhibits a T1-reducing effect, and the resulting compound... Agent: Fitzpatrick Cella Harper & Scinto

20110028714 - Folate mimetics and folate-receptor binding conjugates thereof: A cell population expressing folate receptors is selectively targeted with a folate mimetic. The folate mimetic is conjugated to a diagnostic or therapeutic agent to enable selective delivery of the agent to the targeted cell population.... Agent: Barnes & Thornburg LLP

20110028715 - Novel adenine compound: wherein A represents an (un)substituted aromatic carbocycle or (un)substituted aromatic heterocycle; L1 and L2 each independently represents straightened or branched alkylene, etc.; R1 represents halogen, (un)substituted alkyl, (un)substituted alkenyl, (un)substituted alkynyl, (un)substituted cycloalkyl, (un)substituted aryl, or (un)substituted heteroaryl; R2 and R3 each independently represents hydrogen, or (un)substituted alkyl, (un)substituted alkenyl,... Agent: Birch Stewart Kolasch & Birch